Prestige Consumer Healthcare (PBH) Total Debt Growth (3y) (2014 - 2025)
Prestige Consumer Healthcare (PBH) Total Debt Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - | -2.21% |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn | -7.03% |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn | 11.29% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | 63.29% |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -7.76% |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -14.15% |
| 10 | Prestige Consumer Healthcare | 2.40 Bn | 2.34 Bn | 157.37 Mn | -10.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.13% |
| Sep 30, 2025 | -11.61% |
| Jun 30, 2025 | -12.31% |
| Mar 31, 2025 | -12.41% |
| Dec 31, 2024 | -13.46% |
| Sep 30, 2024 | -13.04% |
| Jun 30, 2024 | -10.95% |
| Mar 31, 2024 | -8.71% |
| Dec 31, 2023 | -8.17% |
| Sep 30, 2023 | -6.56% |
| Jun 30, 2023 | -6.69% |
| Mar 31, 2023 | -8.04% |
| Dec 31, 2022 | -5.76% |
| Sep 30, 2022 | -6.40% |
| Jun 30, 2022 | -6.12% |
| Mar 31, 2022 | -6.36% |
| Dec 31, 2021 | -6.00% |
| Sep 30, 2021 | -5.52% |
| Jun 30, 2021 | -8.14% |
| Mar 31, 2021 | -9.45% |